Heart disease is a growing epidemic in the United States that can lead to heart failure. Heart failure is characterized as a progressive, downward spiral in heart function. In particular, cardiac injury can cause cardiac dysfunction, which results in reduced cardiac output. Some results of reduced cardiac output are endothelial dysfunction, neurohormonal activation, renal impairment, and vasoconstriction. These results can lead to fluid retention and increased systemic vascular resistance. An increase in systemic vascular resistance can create increased cardiac load which can cause further cardiac dysfunction. Thus a cycle of further cardiac dysfunction can be established.
Although there are various treatments proposed and being developed for treating heart failure, such systems are generally limited to the hospital setting or at least require the patient to be very limited in mobility if not completely confined to a bed. Some patients have turned to implantable blood pumps, such as ventricular assist devices (VAD), for assisting in heart pumping or effectively replacing the natural heart's function. Most patients recover in a way where they improve in functional class, however, only a small percentage of patients exhibit restoration to the point of explant and the number of hearts available for heart transplant is insufficient to meet demand. As such, the blood pumps are typically required for life. Accordingly, it may be advantageous to further improve blood pump devices, systems, and methods to coordinate pumping functions and to monitor patient physiological parameters during the long term implantation (e.g., destination therapy or bridge to transplantation) of the implantable blood pump so there is continuing need to improve pumps and LVAD therapy. Here, there is need for pressure reading to better provide therapy and/or actively adjust pump parameters based on the patient. For example, a patient may recover over time and the pump can be adjusted accordingly. Optionally, the pump may be adjusted for patient exercise or activity.
The present invention generally relates to heart pump systems and methods of use. In some embodiments, a method of hemodynamic monitoring is provided for a patient having an implanted heart pump. In further embodiments, a heart pump is provided that may monitor physiological parameters of the patient and may adjust pumping (e.g., speed, mode, flow rate, or the like) in response to the monitored parameters and/or may report the monitored parameters to a physician.
Many rotary blood pumps may estimate flow through the heart pump, for example, by sensing the electrical current required to drive the rotor at a particular speed. This information may be beneficial for clinicians for determining changes in pump performance associated with a physiological state (e.g., suction detection, patient hypertension, etc.). However, the pump flow rate information alone may be of limited value in diagnosing the patient's hemodynamic state and/or determining if the heart pump is providing adequate flow support (or too much or too little). Patients may have dramatically different cardiac output needs and these needs may change depending on a number of factors (e.g., rest, exercise, stress, left ventricular recovery, time of day, etc.).
Cardiovascular pressure measurements can provide a host of valuable data that is directly applicable for determining a patient's hemodynamic state and optimizing blood pump settings. For example, a physician may want to specifically tailor a pump flow rate or pump speed depending on patient characteristics. To determine the appropriate flow rate or speed, the physician may benefit from additional information, such as the left ventricular pressure, pulmonary arterial pressure, etc. There are a number of potential sensor devices and locations applicable to the present invention. In particular, real time high speed (e.g., ˜50 Hz) pressure measurements of the left ventricle and the aorta may be particularly valuable for left ventricular assist device (LVAD) applications. With such measurements, other clinical parameters may be derived, such as systolic arterial pressure, diastolic arterial pressure, mean arterial pressure, systemic resistance estimation, aortic compliance estimation, end diastolic pressure (LV filling pressure), end systolic pressure, LV contractility estimation, degree of aortic valve opening, stroke volume and/or cardiac output estimation. Additionally, pressure measurements may be used to increase the accuracy of flow rate estimations based on drive current, similar to the concepts described in U.S. patent application Ser. No. 15/212,721, the contents of which are incorporated herein by reference in their entirety.
In some embodiments of the present invention, a method for hemodynamic monitoring of a patient may be provided. The method may include receiving a differential pressure across the heart pump having an inflow and an outflow. A pressure measurement may be received from a pressure sensor positioned in the inflow or the outflow of the heart pump. A data waveform of interest may be calculated from the differential pressure across the heart pump and the pressure measurement from the pressure sensor positioned in the inflow or the outflow of the heart pump.
In some embodiments, the calculated data waveform of interest may be outputted (e.g., to a patient or a clinician). In some embodiments, a pumping of the heart pump may be adjusted in response to the calculated data waveform. In some embodiments, the pressure sensor is positioned in the outflow of the heart pump. The differential pressure across the heart pump may be calculated based on a rotor drive current associated with the heart pump. In some embodiments, the data waveform of interest comprises a left ventricular pressure waveform and the left ventricular pressure waveform may be calculated by subtracting the differential pressure from the pressure measurement.
In further aspects of the present invention, a blood pump system may be provided. The system may include a blood pump comprising an inlet and an outlet. A pressure sensor may be provided that is coupled with the inlet or the outlet of the blood pump. A controller operably coupled with the blood pump and the pressure sensor may be configured to receive a differential pressure across the blood pump and a pressure measurement from the pressure sensor. The controller may be configured to calculate a data waveform of interest from the differential pressure across the blood pump and the pressure measurement from the pressure sensor.
In some embodiments, the controller is configured to output the calculated data waveform. Optionally, the controller is configured to adjust a pumping of the heart pump in response to the calculated data waveform. In some embodiments, the sensor is positioned on the outflow of the blood pump. In some embodiments, the controller calculates the differential pressure across the blood pump based on a rotor driver current associated with the blood pump. In certain embodiments, the data waveform of interest comprises a left ventricular pressure waveform and the left ventricular pressure waveform may be calculated by subtracting the differential pressure from the pressure measurement.
Embodiments of the disclosure covered by this patent are defined by the claims below, not this summary. This summary is a high-level overview of various aspects of the invention and introduces some of the concepts that are further described in the Detailed Description section below. This summary is not intended to identify key or essential features of the claimed subject matter, nor is it intended to be used in isolation to determine the scope of the claimed subject matter. The subject matter should be understood by reference to appropriate portions of the entire specification of this patent, any or all drawings, and each claim.
The disclosure will be better understood upon reading the following description and examining the figures which accompany it. These figures are provided by way of illustration only and are in no way limiting on the invention.
Further details, aspects, and embodiments of the invention will be described by way of example only and with reference to the drawings. In the drawings, like reference numbers are used to identify like or functionally similar elements. Elements in the figures are illustrated for simplicity and clarity and have not necessarily been drawn to scale.
Method 100 may be used to estimate the left ventricular pressure waveform. Additionally, the aortic pressure waveform may be calculated separate from or in addition to the left ventricular pressure waveform. With such measurements, other clinical parameters may be derived, such as: systolic arterial pressure, diastolic arterial pressure, mean arterial pressure, systemic resistance estimation, aortic compliance estimation, end diastolic pressure (LV filling pressure), end systolic pressure, LV contractility estimation, degree of aortic valve opening, stroke volume and cardiac output estimation. While generally discussed as estimating parameters associated with the left ventricle, it should be understood that the method 100 is applicable to measuring parameters associated with other chambers of the heart (e.g., right ventricle, left atrium, etc.), depending on where the heart pump is implanted.
Controller 203 may be an on-board controller of heart pump 202 or may be an external controller (e.g., coupled to the heart pump 202 through a percutaneous cable, wirelessly, or the like). Controller 203 may be operably coupled with the motor 206 and the pressure sensor 210 and may receive a rotor drive current signal 212 and a pressure sensor signal 214 from the heart pump 202. With the received rotor drive current signal 212, the controller 203 may estimate a pump flow by accessing a lookup table 216 associating the received current signal (I) to pump flow rate (Q).
The controller 203 may also be configured to adjust the pumping operation of the pump in response to the estimated VAD flow waveform 218, the left ventricular pressure waveform 222, and/or the aortic pressure waveform 224. For example, in some embodiments, the left ventricular pressure waveform 222 may be associated with a heart rate of a patient, thereby providing patient activity information. The heart rate may be automatically calculated by analyzing the rate of left ventricular pressure change in the estimated left ventricular pressure waveform 222 which can also indicates the start of systole. In some embodiments, a threshold rate of left ventricular pressure change may be used to identify individual heart beats in the calculated left ventricular pressure waveform. With changes in heart rate or activity of a patient, a pumping operation of a heart pump 202 may be increased (during increased heart rate/activity) or decreased (during decreased heart rate/activity) in response. This may be particularly advantageous as separate patient heart rate sensor or activity monitor may not be needed, thereby possibly reducing complexity and power consumption of a system 200.
In addition, a left ventricular contractility estimate may be estimated based on the left ventricular pressure waveform. For example, the contractility estimate may be associated with a gradient of a train of the left ventricular pressure waveform.
The measured pressure may act as a proxy for one or more other clinical parameters, including but not limited to filling pressure, systolic arterial pressure, diastolic arterial pressure, mean arterial pressure, systemic resistance estimation, aortic compliance estimation, end diastolic pressure, end systolic pressure, LV contractility estimation, degree of aortic valve opening, and/or stroke volume and cardiac output estimation. For example, a left ventricular pressure waveform and an aortic pressure waveform may be used to calculate one or more of the above parameters.
While heart pump 202 is generally illustrated as a centrifugal flow heart pump, it should be understood that heart pump 202 may have other configurations. For example, in some embodiments, heart pump 202 may be an axial flow blood pump or a mixed flow blood pump.
Pressure sensor may be interrogated at a fast rate (˜50 Hz) in combination with rotor torque measurements to provide real-time waveforms for LV pressure, VAD flow, and aortic pressure. Further, as mentioned above pressure sensor 210 may be integrated in the inflow of heart pump 202. For example,
Alternatively, the pressure sensor 210 may be connected via flying lead (wired). In some embodiments, it may be advantageous to integrate the sensor 210 directly into the pump housing. For example, the sensor 210 could be directly wired to the motor electronics and the sensor 210 itself may be well protected from damage during use. In addition, the volute/outflow is typically less prone to tissue buildup/fouling than the LV or pump inflow. In such embodiments, the sensor 210 may be located anywhere from the volute to the aorta.
Many traditional sensors could be used, including MEMS, strain gauges, piezo-based sensors, capacitive sensors, transonic, ultrasound Doppler, or the like. U.S. Provisional Patent Application No. 62/194,700 and U.S. Provisional Patent Application No. 62/194,608 describe pressure sensor configurations and pressure sensing methods that may be utilized in embodiments of the present disclosure. The contents of each provisional patent application are incorporated herein in their entirety for all purposes.
Additionally, heart pump 202 is generally described for implantation in the left ventricle and for estimation of left ventricular parameters, but heart pump 202 may also be configured to couple with other portions of the heart. For example, in some embodiments, heart pump 202 may couple with the right ventricle, as illustrated in
In still further embodiments of the present disclosure, a pressure differential across the pump may be received from a plurality of pressure sensors of the heart pump in the alternative to (or in addition to) computing the pressure differential based on a rotor drive current signal. For example,
One or more computing devices may be adapted to provide desired functionality by accessing software instructions rendered in a computer-readable form. When software is used, any suitable programming, scripting, or other type of language or combinations of languages may be used to implement the teachings contained herein. However, software need not be used exclusively, or at all. For example, some embodiments of the methods and systems set forth herein may also be implemented by hard-wired logic or other circuitry, including but not limited to application-specific circuits. Combinations of computer-executed software and hard-wired logic or other circuitry may be suitable as well.
Embodiments of the methods disclosed herein may be executed by one or more suitable computing devices. Such system(s) may comprise one or more computing devices adapted to perform one or more embodiments of the methods disclosed herein. As noted above, such devices may access one or more computer-readable media that embody computer-readable instructions which, when executed by at least one computer, cause the at least one computer to implement one or more embodiments of the methods of the present subject matter. Additionally or alternatively, the computing device(s) may comprise circuitry that renders the device(s) operative to implement one or more of the methods of the present subject matter.
Any suitable computer-readable medium or media may be used to implement or practice the presently-disclosed subject matter, including but not limited to, diskettes, drives, and other magnetic-based storage media, optical storage media, including disks (e.g., CD-ROMS, DVD-ROMS, variants thereof, etc.), flash, RAM, ROM, and other memory devices, and the like.
In the description above, various embodiments of the present invention are described. For purposes of explanation, specific configurations and details are set forth in order to provide a thorough understanding of the embodiments. However, it will also be apparent to one skilled in the art that the present invention may be practiced without the specific details. Furthermore, well-known features may be omitted or simplified in order not to obscure the embodiment being described. The subject matter of the present invention is described here with specificity, but the claimed subject matter may be embodied in other ways, may include different elements or steps, and may be used in conjunction with other existing or future technologies.
This description should not be interpreted as implying any particular order or arrangement among or between various steps or elements except when the order of individual steps or arrangement of elements is explicitly described. Different arrangements of the components depicted in the drawings or described above, as well as components and steps not shown or described are possible. Similarly, some features and sub-combinations are useful and may be employed without reference to other features and sub-combinations. Embodiments of the invention have been described for illustrative and not restrictive purposes, and alternative embodiments will become apparent to readers of this patent. Accordingly, the present invention is not limited to the embodiments described above or depicted in the drawings, and various embodiments and modifications may be made without departing from the scope of the claims below.
Other variations are within the spirit of the present invention. Thus, while the invention is susceptible to various modifications and alternative constructions, certain illustrated embodiments thereof are shown in the drawings and have been described above in detail. It should be understood, however, that there is no intention to limit the invention to the specific form or forms disclosed, but on the contrary, the intention is to cover all modifications, alternative constructions, and equivalents falling within the spirit and scope of the invention, as defined in the appended claims.
The use of the terms “a” and “an” and “the” and similar referents in the context of describing the invention (especially in the context of the following claims) are to be construed to cover both the singular and the plural, unless otherwise indicated herein or clearly contradicted by context. The terms “comprising,” “having,” “including,” and “containing” are to be construed as open-ended terms (i.e., meaning “including, but not limited to,”) unless otherwise noted. The term “connected” is to be construed as partly or wholly contained within, attached to, or joined together, even if there is something intervening. Recitation of ranges of values herein are merely intended to serve as a shorthand method of referring individually to each separate value falling within the range, unless otherwise indicated herein, and each separate value is incorporated into the specification as if it were individually recited herein. All methods described herein can be performed in any suitable order unless otherwise indicated herein or otherwise clearly contradicted by context. The use of any and all examples, or exemplary language (e.g., “such as”) provided herein, is intended merely to better illuminate embodiments of the invention and does not pose a limitation on the scope of the invention unless otherwise claimed. No language in the specification should be construed as indicating any non-claimed element as essential to the practice of the invention.
Preferred embodiments of this invention are described herein, including the best mode known to the inventors for carrying out the invention. Variations of those preferred embodiments may become apparent to those of ordinary skill in the art upon reading the foregoing description. The inventors expect skilled artisans to employ such variations as appropriate, and the inventors intend for the invention to be practiced otherwise than as specifically described herein. Accordingly, this invention includes all modifications and equivalents of the subject matter recited in the claims appended hereto as permitted by applicable law. Moreover, any combination of the above-described elements in all possible variations thereof is encompassed by the invention unless otherwise indicated herein or otherwise clearly contradicted by context.
All references, including publications, patent applications, and patents, cited herein are hereby incorporated by reference to the same extent as if each reference were individually and specifically indicated to be incorporated by reference and were set forth in its entirety herein.
The present application claims the benefit of U.S. Provisional Application No. 62/478,492, filed Mar. 29, 2017, the entire contents of which are hereby incorporated by reference herein.
Number | Name | Date | Kind |
---|---|---|---|
3911897 | Leachman | Oct 1975 | A |
5139517 | Corral | Aug 1992 | A |
5318592 | Schaldach | Jun 1994 | A |
5503615 | Goldstein | Apr 1996 | A |
6066086 | Antaki et al. | May 2000 | A |
6111520 | Allen et al. | Aug 2000 | A |
6176822 | Nix | Jan 2001 | B1 |
6278379 | Allen et al. | Aug 2001 | B1 |
6585635 | Aldrich | Jul 2003 | B1 |
6634224 | Schoeb et al. | Oct 2003 | B1 |
6643420 | Han et al. | Nov 2003 | B2 |
6772011 | Dolgin et al. | Aug 2004 | B2 |
6855115 | Fonseca et al. | Feb 2005 | B2 |
6984201 | Khaghani et al. | Jan 2006 | B2 |
7029433 | Chang | Apr 2006 | B2 |
7245117 | Joy et al. | Jul 2007 | B1 |
7320706 | Al-Najjar | Jan 2008 | B2 |
7439723 | Allen et al. | Oct 2008 | B2 |
7498799 | Allen et al. | Mar 2009 | B2 |
7520850 | Brockway | Apr 2009 | B2 |
7550978 | Joy et al. | Jun 2009 | B2 |
7679355 | Allen et al. | Mar 2010 | B2 |
7839153 | Joy et al. | Nov 2010 | B2 |
7853325 | Dabney et al. | Dec 2010 | B2 |
7862501 | Woodard | Jan 2011 | B2 |
7945333 | Jacobson | May 2011 | B2 |
7963905 | Salmonsen et al. | Jun 2011 | B2 |
7988728 | Ayre | Aug 2011 | B2 |
7998054 | Bolling | Aug 2011 | B2 |
8145324 | Stevenson et al. | Mar 2012 | B1 |
8177838 | Vodermayer et al. | May 2012 | B2 |
8180448 | Stevenson et al. | May 2012 | B2 |
8224462 | Westlund et al. | Jul 2012 | B2 |
8246530 | Sullivan | Aug 2012 | B2 |
8295939 | Jacobson | Oct 2012 | B2 |
8364283 | Halperin et al. | Jan 2013 | B2 |
8506471 | Bourque | Aug 2013 | B2 |
8543205 | Ostroff | Sep 2013 | B2 |
8608636 | Choi et al. | Dec 2013 | B2 |
8657733 | Ayre et al. | Feb 2014 | B2 |
8682431 | Callaway et al. | Mar 2014 | B2 |
8712544 | Dabney et al. | Apr 2014 | B2 |
8771165 | Choi et al. | Jul 2014 | B2 |
8794989 | Kearsley et al. | Aug 2014 | B2 |
8852099 | Von Arx et al. | Oct 2014 | B2 |
8864644 | Yomtov | Oct 2014 | B2 |
8894561 | Callaway et al. | Nov 2014 | B2 |
8897887 | Halperin et al. | Nov 2014 | B2 |
9039595 | Ayre et al. | May 2015 | B2 |
9090271 | Bartonek | Jul 2015 | B2 |
9387284 | Heilman et al. | Jul 2016 | B2 |
9433714 | Voskoboynikov et al. | Sep 2016 | B2 |
9579432 | Tamez et al. | Feb 2017 | B2 |
9579435 | Yomtov | Feb 2017 | B2 |
9592327 | Wariar et al. | Mar 2017 | B2 |
9833552 | Yomtov | Dec 2017 | B2 |
20050071001 | Jarvik | Mar 2005 | A1 |
20070088397 | Jacobson | Apr 2007 | A1 |
20080281146 | Morello | Nov 2008 | A1 |
20100241223 | Lee et al. | Sep 2010 | A1 |
20110178361 | Yomtov | Jul 2011 | A1 |
20110270331 | Peters et al. | Nov 2011 | A1 |
20130072846 | Heide et al. | Mar 2013 | A1 |
20140012067 | Poirier | Jan 2014 | A1 |
20140046120 | Choi et al. | Feb 2014 | A1 |
20140058190 | Gohean et al. | Feb 2014 | A1 |
20140188148 | Le Blanc et al. | Jul 2014 | A1 |
20150057488 | Yomtov | Feb 2015 | A1 |
20150073203 | Wariar et al. | Mar 2015 | A1 |
20150148587 | Bourque | May 2015 | A1 |
20150151032 | Voskoboynikov et al. | Jun 2015 | A1 |
20150174307 | Eckman et al. | Jun 2015 | A1 |
20150290374 | Bourque et al. | Oct 2015 | A1 |
20150328466 | Peters et al. | Nov 2015 | A1 |
20160058929 | Medvedev et al. | Mar 2016 | A1 |
20160058930 | Medvedev et al. | Mar 2016 | A1 |
20160101230 | Ochsner et al. | Apr 2016 | A1 |
20160193397 | Aber et al. | Jul 2016 | A9 |
20160228628 | Medvedev et al. | Aug 2016 | A1 |
20160263299 | Xu et al. | Sep 2016 | A1 |
20170021070 | Petersen | Jan 2017 | A1 |
20170080138 | Yomtov | Mar 2017 | A1 |
20170128646 | Karch | May 2017 | A1 |
20180050348 | Whitney | Feb 2018 | A1 |
20180078689 | Yomtov | Mar 2018 | A1 |
20180140760 | Cotter | May 2018 | A1 |
20180280599 | Harjes et al. | Oct 2018 | A1 |
20180280600 | Harjes et al. | Oct 2018 | A1 |
Number | Date | Country |
---|---|---|
2570143 | Mar 2013 | EP |
3 213 781 | Sep 2017 | EP |
2007089500 | Aug 2007 | WO |
2011123789 | Oct 2011 | WO |
2016001284 | Jan 2016 | WO |
2016137743 | Sep 2016 | WO |
2017117185 | Jul 2017 | WO |
2017117215 | Jul 2017 | WO |
2017139113 | Aug 2017 | WO |
Entry |
---|
Bedi et al., “Ventricular Arrhythmias During Left Ventricular Assist Device Support”, Am J Cardiol., vol. 99, Issue 8, 2007, pp. 1151-1153. |
Brisco et al., “The Incidence, Risk, and Consequences of Atrial Arrhythmias In Patients With Continuous-flow Left Ventricular Assist Devices”, J Card Surg, vol. 29, Issue 4, 2014, pp. 572-580. |
Clark et al., “Hemodynamic Effects of An Irregular Sequence of Ventricular Cycle Lengths During Atrial Fibrillation”, Journal of the American College of Cardiology, vol. 30, Issue 4, 2007, pp. 1039-1045. |
Enriquez et al., “Clinical Impact of Atrial Fibrillation In Patients With The Heartmate Ii Left Ventricular Assist Device”, Journal of the American College of Cardiology, vol. 64, Issue 18, 2014, pp. 1883-1890. |
Hayward et al., “Effect of Alteration In Pump Speed on Pump Output and Left Ventricular Filling With Continuous-flow Left Ventricular Assist Device”, ASAIO Journal. vol. 57, issue 6, 2011, pp. 495-500. |
Maeda et al., “Predictive Control by Physical Activity Rate of a Total Artificial Heart During Exercise”, Transactions of the American Society of Artificial Internal Organs, vol. 34, 1988, pp. 480-484. |
Maury et al., “First Experience of Percutaneous Radio-frequency Ablation for Atrial Flutter and Atrial Fibrillation In A Patient With Heartmate Ii Left Ventricular Assist Device”, Journal of Interventional Cardiac Electrophysiology, vol. 29, Issue 1, 2010, pp. 63-67. |
Oswald et al., “Implantable Defibrillator Therapy for Ventricular Tachyarrhythmia In Left Ventricular Assist Device Patients”, Eur J Heart Fail., vol. 12, Issue 6, 2010, pp. 593-599. |
Oz et al., “Malignant Ventricular Arrhythmias Are Well Tolerated In Patients Receiving Long-term Left Ventricular Assist Devices”, Journal of the American College of Cardiology, vol. 24, Issue 7, 1994, pp. 1688-1691. |
Raasch et al., “Epidemiology, Management, and Outcomes of Sustained Ventricular Arrhythmias After Continuous-flow Left Ventricular Assist Device Implantation”, Am Heart J., vol. 164, Issue 3, 2012, pp. 373-378. |
Ziv et al., “Effects of Left Ventricular Assist Device Therapy on Ventricular Arrhythmias”, Journal of the American College of Cardiology, vol. 45, Issue 9, 2005, pp. 1428-1434. |
Number | Date | Country | |
---|---|---|---|
20180280601 A1 | Oct 2018 | US |
Number | Date | Country | |
---|---|---|---|
62478492 | Mar 2017 | US |